glutathione and heart failure Participation in the Prevention of Cardiovascular Diseases Role of Glutaredoxin-1 and Glutathionylation

Recent FDA actions include interim category lists that restrict or preclude the use of certain bulk drug substances in compounding unless the active pharmaceutical ingredient is listed or the product is being studied under an IND

BPC-157, or Body Protection Compound 157, is a peptide known for its remarkable ability to promote healing and repair tissues

GLOW sits within our broader peptide therapy program, where it can be considered alongside hormone optimization, NAD+ therapy, and other interventions for patients seeking regenerative results

Abstract We revealed that the stable gastric pentadecapeptide BPC 157, a useful peptide therapy against isoprenaline myocardial infarction, as well as against isoprenaline myocardial reinfarction, may follow the counteraction of the recently described occlusion-like syndrome, induced peripherally and centrally, which was described for the first time in isoprenaline-treated rats